Affordable cancer treatment still out of reach for many

Advances in oncology have widened treatment options, yet many patients cannot afford to complete the prescribed course. The recent decision to cap trade margins on 137 identified non-scheduled anti-cancer medicines offers some relief, but the long battle for affordable care continues.